Synergistic Effect of a Retinoid X Receptor-Selective Ligand Bexarotene and Docetaxel in Prostate Cancer [Corrigendum]

OncoTargets and Therapy - New Zealand
doi 10.2147/ott.s235000
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Ligand-Dependent Heterodimerization of Thyroid Hormone Receptor and Retinoid X Receptor

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
1997English

Synergistic Effect of Geranylgeranyltransferase Inhibitor, GGTI, and Docetaxel on the Growth of Prostate Cancer Cells

Prostate Cancer
Cancer ResearchOncologyUrology
2012English

Docetaxel and Doxorubicin Codelivery by Nanocarriers for Synergistic Treatment of Prostate Cancer

Frontiers in Pharmacology
Pharmacology
2019English

Retinoid X Receptor Antagonists

2018English

Mutations That Alter Ligand-Induced Switches and Dimerization Activities in the Retinoid X Receptor.

Molecular and Cellular Biology
Cell BiologyMolecular Biology
1994English

The Effect of Antagonists on the Conformational Exchange of the Retinoid X Receptor Alpha Ligand-Binding Domain

Magnetic Resonance in Chemistry
Materials ScienceChemistry
2009English

Selective Ligand Activity at Nur/Retinoid X Receptor Complexes Revealed by Dimer-Specific Bioluminescence Resonance Energy Transfer-Based Sensors

FASEB Journal
BiochemistryBiotechnologyGeneticsMolecular BiologyMedicine
2015English

Mouse Retinoid X Receptor Contains a Separable Ligand-Binding and Transactivation Domain in Its E Region.

Molecular and Cellular Biology
Cell BiologyMolecular Biology
1995English

Interaction Between the Retinoid X Receptor and Transcription Factor IIB Is Ligand-Dependentin Vivo

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
1998English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy